Dr Reddys Laboratories

Rediff.com » News » Dr Reddys Laboratories

News for Dr Reddys Laboratories

News
Business

Dr Reddy's Laboratories loses Rs 2.16 cr in cyber fraud

The Bengaluru police have launched a probe into a cyber fraud case where hackers allegedly infiltrated the official email communication between Bengaluru-based Group Pharmaceuticals and Dr Reddy's......

Delhi asks Dr Reddy's for 67L doses of Sputnik V vaccine

Amid vaccine shortage faced by Delhi, Chief Minister Arvind Kejriwal on Saturday said his government has written to Dr Reddy's Laboratories for supply of around 67 lakh doses of Russian COVID-19......

Mandaviya meets Dr Reddy's Lab chief on Sputnik V production

Union Health Minister Mansukh Mandaviya on Thursday said he has held a meeting with Dr Reddy's Laboratories Chairman Satish Reddy regarding the production and supply of COVID-19 vaccine Sputnik V.......

Dr Reddy's launches Covid drug 2-DG at Rs 990 per sachet

Drug major Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet. IMAGE:......

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad. IMAGE:......

Non-US uptick seen driving gains for Dr Reddy's Labs

Motilal Oswal Research said Dr Reddy’s Labs delivered a better than expected Q3FY26, with strong execution in India, Europe and Russia, and favourable currency movement more than offsetting the......

Dr Reddy's profit down 14% on low Lenalidomide US sales

In the October to December period of FY26, DRL recorded a 12 per cent Y-o-Y drop in revenue from North America to Rs 2,964 crore from Rs 3,383 crore due to continued price erosion in Lenalidomide.......

Margin pressures, growth triggers to weigh on Dr Reddy's

Pharma major Dr Reddy’s Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. IMAGE: Satish......

US patent lawsuit against Dr Reddy's

US-based drug discovery firm Albany Molecular Research, Inc (Amri) has filed two new patent infringement lawsuits in the US District Court in New Jersey against Dr. Reddy's Laboratories Ltd., Dr.......

Atorvastatin: Dr Reddy's to contest Pfizer's suit

Drug maker Dr Reddy's Laboratories will contest the patent infringement case filed against it by the global pharmaceutical giant Pfizer over its cholesterol lowering drug atorvastatin, said a......

Dr Reddys Laboratories

News for Dr Reddys Laboratories